journal article·2019-11

Passive and active targeting strategies in hybrid layered double hydroxides nanoparticles for tumor bioimaging and therapy

Karina Nava Andrade, Ana María Puebla Pérez, Gregorio Guadalupe Carbajal Arízaga

Publisher page

Abstract

Abstract Layered double hydroxides (LDH) are recognized as a base to prepare a wide range of materials owing the versatility to modify the composition and structure of the particles, some of them with nanometric sizes. Within the biomedical science, there is a rising interest in preparing multifunctional materials to treat or identify cancer cells. This review presents three levels of molecular engineering techniques used to hybridize LDH nanoparticles aiming to produce multifunctional materials with a specific action in malignant tumors. The first level has been more developed and is related to modify the composition of the layered structure and interlayer spaces, whereas the other levels belong to more advanced strategies involving the assembly of different components. All the levels lead to produce hybrid materials, and the goal of this review is to correlate the molecular engineering techniques with the active and passive targeting mechanisms that promote the accumulation of the hybrid LDH nanoparticles in the desired cells and promote a more effective treatment or diagnosis. Finally, a discussion on the lack of information will be presented in order to identify the following the research questions that must be addressed to improve the state of the art before these particles were translated to clinical assays.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Layered Double Hydroxides Synthesis and Applications · Inorganic Chemistry and Materials · Magnesium Oxide Properties and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Chemical modification of zinc hydroxide nitrate and Zn-Al-layered double hydroxide with dicarboxylic acids10.1016/j.jcis.2007.12.038 ↗
2. Folate-intercalated layered double hydroxide as a vehicle for cyclophosphamide, a non-ionic anti-cancer drug10.1049/mnl.2016.0106 ↗
3. Dysprosium-containing layered double hydroxides nanoparticles intercalated with biologically active species as an approach for theranostic systems10.1016/j.mseb.2015.10.004 ↗
4. Benito · 2006 · vol. 94 · 148
5. Exploiting tumour hypoxia in cancer treatment10.1038/nrc1367 ↗
6. Inorganic metal hydroxide nanoparticles for targeted cellular uptake through clathrin-mediated endocytosis10.1002/asia.200800290 ↗
7. Reduction in the size of layered double hydroxide nanoparticles enhances the efficiency of SiRNA delivery10.1016/j.jcis.2012.09.033 ↗
8. Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics10.2147/IJN.S45429 ↗
9. Encapsulation of palladium porphyrin photosensitizer in layered metal oxide nanoparticles for photodynamic therapy against skin melanoma10.1088/1468-6996/16/5/054205 ↗
10. Intercalation of organic and inorganic anions into layered double hydroxides10.1039/c39890000926 ↗
11. Layered double hydroxide nanoparticles as target-specific delivery carriers: uptake mechanism and toxicity10.2217/nnm.11.86 ↗
12. Biocompatible ceramic nanocarrier for drug delivery with high efficiency10.2109/jcersj2.117.543 ↗
13. Choi · 2011
14. Inorganic nanovehicle targets tumor in an orthotopic breast cancer model10.1038/srep04430 ↗
15. Anionic clay as the drug delivery vehicle: tumor targeting function of layered double hydroxide- methotrexate nanohybrid in C33A orthotopic cervical cancer model10.2147/IJN.S95611 ↗
16. 2D nanostructured metal hydroxides with gene delivery and theranostic functions; a comprehensive review10.1002/tcr.201700091 ↗
17. Emerging nanomaterials with advanced drug delivery functions; focused on methotrexate delivery10.1016/j.ccr.2018.01.007 ↗
18. Intercalative nanohybrids of nucleoside monophosphates and DNA in layered metal hydroxide10.1021/ja981823f ↗
19. Inorganic layered double hydroxides as nonviral vectors10.1002/1521-3757(20001117)112:22<4207::AID-ANGE4207>3.0.CO;2-H ↗
20. Layered double hydroxides and human health: an overview10.1016/j.clay.2006.06.010 ↗
21. Layered double hydroxide modified by PEGylated hyaluronic acid as a hybrid nanocarrier for targeted drug delivery10.1007/s12209-016-2710-2 ↗
22. Stimuli-responsive nanoparticles for targeting the tumor microenvironment10.1016/j.jconrel.2015.08.050 ↗
23. Layered double hydroxides
24. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study global burden10.1001/jamaoncol.2016.5688 ↗
25. RGD peptide-based non-viral gene delivery vectors targeting integrin α v β 3 for cancer therapy
26. Graphene oxide as support for layered double hydroxides: enhancing the CO2 adsorption capacity10.1021/cm3018264 ↗
27. A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics10.1016/j.acthis.2010.02.004 ↗
28. Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting
29. Antibody-targeted drug delivery to injured arteries using layered double hydroxide nanoparticles10.1002/adhm.201200069 ↗
30. A layered drug nanovehicle toward targeted cancer imaging and therapy10.1039/C5TB02521D ↗
31. A supramolecular material for dual-modal imaging and targeted cancer therapy10.1016/j.talanta.2016.12.068 ↗
32. An NIR-sensitive layered supramolecular nanovehicle for combined dual-modal imaging and synergistic therapy10.1039/C7NR01771E ↗
33. Supramolecular assembly and magnetic targeted slow-release effect of ‘dextran-magnetic layered double hydroxide-fluorouracil’ drug delivery system
34. Understanding the warburg effect: the metabolic requirements of cell proliferation10.1126/science.1160809 ↗
35. Applied clay science size control and optimisation of intercalated layered double hydroxides
36. Study on Cytotoxicity of ‘Dextran-Magnetic Layered Double Hydroxide – Fluorouracil’ Targeted Liposomes in Vitro10.4028/www.scientific.net/AMM.320.526 ↗
37. Effective inhibition of colon cancer cell growth with MgAl-layered double hydroxide (LDH) loaded 5-FU and PI3K/MTOR dual inhibitor BEZ-235 through apoptotic pathways
38. Synthesis and cell imaging of a near-infrared fluorescent magnetic ‘CdHgTe-dextran-magnetic layered double hydroxide-fluorouracil’ composite10.1016/j.xphs.2016.02.030 ↗
39. Hierarchical coated metal hydroxide nanoconstructs as potential controlled release carriers of photosensitizer for skin melanoma10.1039/C4RA16957C ↗
40. Multi-laminated metal hydroxide nanocontainers for oral-specific delivery for bioavailability improvement and treatment of inflammatory paw edema in mice10.1016/j.jcis.2015.07.044 ↗
41. Overcoming multidrug resistance through co-delivery of ros-generating nano-machinery in cancer therapeutics10.1039/C6TB03146C ↗
42. Hybrid materials – past, present and future
43. Targeted molecular imaging10.3348/kjr.2003.4.4.201 ↗
44. Will mandatory folic acid fortification prevent or promote cancer?10.1093/ajcn/80.5.1123 ↗
45. In-vitro evaluation of layered double hydroxide–Fe3O4 magnetic nanohybrids for thermo-chemotherapy10.1039/C5NJ01701G ↗
46. Layered double hydroxide nanoparticles to enhance organ-specific targeting and the anti-proliferative effect of cisplatin10.1039/C4TB01989J ↗
47. Layered double hydroxide nanocomposite for drug delivery systems; bio-distribution, toxicity and drug activity enhancement10.1186/s13065-014-0047-2 ↗
48. Layered double hydroxide nanoparticles for biomedical applications: current status and recent prospects10.1016/j.clay.2015.04.018 ↗
49. Targeting strategies for the combination treatment of cancer using drug delivery systems10.3390/pharmaceutics9040046 ↗
50. Targeting C-type lectin receptors with multivalent carbohydrate ligands10.1016/j.addr.2013.05.007 ↗
51. Poly(ethylene glycol) haired layered double hydroxides as biocompatible nanovehicles: morphology and dispersity study10.1016/j.colsurfa.2011.05.012 ↗
52. Cellular uptake and gene delivery using layered double hydroxide nanoparticles10.1039/C2TB00081D ↗
53. Cancer therapy and fluorescence imaging using the active release of doxorubicin from MSPs/Ni-LDH folate targeting nanoparticles10.1016/j.biomaterials.2013.06.046 ↗
54. A targeted agent with intercalation structure for cancer near-infrared imaging and photothermal therapy
55. Mannose-conjugated layered double hydroxide nanocomposite for targeted SiRNA delivery to enhance cancer therapy
56. A tumor-PH-responsive supramolecular photosensitizer for activatable photodynamic therapy with minimal in vivo skin phototoxicity10.7150/thno.18861 ↗
57. Engineered PH-responsive hydrazone-carboxylate complexes-encapsulated 2D matrices for cathepsin-mediated apoptosis in cancer10.1002/jbm.a.36610 ↗
58. Folate-targeted therapeutic and imaging agents for cancer10.1016/j.cbpa.2009.03.022 ↗
59. Layered double hydroxide assemblies with controllable drug loading capacity and release behavior as well as stabilized layer-by-layer polymer multilayers10.1021/acsami.5b04569 ↗
60. Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting10.2183/pjab.88.53 ↗
61. Layered double hydroxide bio-composites toward excellent systematic anticancer therapy10.1039/C7TB00209B ↗
62. Layered double hydroxides: a brief review from fundamentals to application as evolving biomaterials10.1016/j.clay.2017.12.021 ↗
63. Clay nanosheets for topical delivery of RNAi for sustained protection against plant viruses
64. Induction of virus resistance by exogenous application of double-stranded RNA10.1016/j.coviro.2017.07.009 ↗
65. Anion-exchange properties of hydrotalcite-like compounds10.1346/CCMN.1983.0310409 ↗
66. Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles10.1124/pr.111.005363 ↗
67. Synthesis and investigation of magnetic nanocomposite of Fe3O4 with cetirizine-intercalated layered double hydroxide10.1016/j.spmi.2014.07.040 ↗
68. The effect of synthetic conditions on tailoring the size of hydrotalcite particles10.1016/S0167-2738(02)00725-7 ↗
69. Cellular uptake mechanism of an inorganic nanovehicle and its drug conjugates: enhanced efficacy due to clathrin-mediated endocytosis10.1021/bc0601323 ↗
70. Inorganic drug-delivery nanovehicle conjugated with cancer-cell-specific ligand10.1002/adfm.200801127 ↗
71. Inorganic metal hydroxide nanoparticles for targeted cellular uptake through clathrin-mediated endocytosis10.1002/asia.200800290 ↗
72. LDH nanocontainers as bio-reservoirs and drug delivery carriers10.2174/187221012803531538 ↗
73. Layered double hydroxide surface modified with (3-aminopropyl)triethoxysilane by covalent bonding10.1002/adma.200400135 ↗
74. Bio-layered double hydroxides nanohybrids for theranostics applications
75. Biodegradable inorganic nanovector: passive versus active tumor targeting in sirna transportation10.1002/anie.201510844 ↗
76. Nano-Oncologicals
77. Enzyme-responsive nanoparticles for drug release and diagnostics10.1016/j.addr.2012.01.002 ↗
78. Antibody fragments as nanoparticle targeting ligands: a step in the right direction10.1039/C6SC02403C ↗
79. Intercalation of drugs in layered double hydroxides and their controlled release: a review10.1016/j.clay.2013.12.002 ↗
80. Peptides for tumor-specific drug targeting: state of the art and beyond10.1039/C7TB00318H ↗
81. Magnesium, zinc and calcium aluminium layered double hydroxide-drug nanohybrids: a comprehensive study10.1016/j.clay.2016.09.030 ↗
82. Chelator-Free Labeling of Layered Double Hydroxide Nanoparticles for in Vivo Pet Imaging
83. Targeted drug delivery via the folate receptor10.1016/S0169-409X(99)00062-9 ↗
84. Yue · 2013 · 320 · 529
85. Functionalized ceramics for biomedical, biotechnological and environmental applications10.1016/j.actbio.2013.03.036 ↗
86. Energy and structure of bonds in the interaction of organic anions with layered double hydroxide nanosheets : a molecular dynamics study
87. Effect of the protein corona on the colloidal stability and reactivity of LDH-based nanocarriers10.1039/C5TB02698A ↗
88. Recent advances in the synthesis and application of layered double hydroxide (LDH) nanosheets10.1021/cr200434v ↗
89. A Gd-doped Mg-Al-LDH/Au nanocomposite for CT/MR bimodal imagings and simultaneous drug delivery10.1016/j.biomaterials.2013.01.070 ↗
90. Stimuli-responsive programmed specific targeting in nanomedicine10.1021/acsnano.6b00870 ↗
91. Etoposide loaded layered double hydroxide nanoparticles reversing chemoresistance and eradicating human glioma stem cells: in vitro and in vivo10.1039/C8NR02708K ↗
92. Dysregulated PH: a Perfect storm for cancer progression10.1038/nrc3110 ↗
93. Synthesis of chitosan-coated near-infrared layered double hydroxide nanoparticles for in vivo optical imaging10.1039/c2jm16447g ↗
94. Synthesis and characterization of chitosan-coated near-infrared (NIR) layered double hydroxide-indocyanine green nanocomposites for potential applications in photodynamic therapy10.3390/ijms160920943 ↗
95. Exogenous application of RNAi-inducing double-stranded RNA inhibits aphid-mediated transmission of a plant virus
96. Synthesis and in vitro evaluation of PH-sensitive magnetic nanocomposites as methotrexate delivery system for targeted cancer therapy10.1016/j.msec.2016.09.084 ↗
97. Dispersion and size control of layered double hydroxide nanoparticles in aqueous solutions10.1021/jp062281o ↗
98. Subcellular compartment targeting of layered double hydroxide nanoparticles10.1016/j.jconrel.2008.05.021 ↗
99. Folic acid conjugated self-assembled layered double hydroxide nanoparticles for high-efficacy-targeted drug delivery10.1039/c3cc45714a ↗
100. Improvement of pharmacokinetic and antitumor activity of layered double hydroxide nanoparticles by coating with PEGylated phospholipid membrane